Artal Group
Latest statistics and disclosures from Artal Group's latest quarterly 13F-HR filing:
- Top 5 stock holdings are CAVA, LXRX, SRRK, KYMR, ARWR, and represent 65.43% of Artal Group's stock portfolio.
- Added to shares of these 10 stocks: ARWR (+$69M), CRNX (+$65M), MDGL (+$30M), XBI (+$24M), VERA (+$22M), SLDB (+$21M), VKTX (+$21M), MRUS (+$21M), KYMR (+$20M), NAMS (+$19M).
- Started 34 new stock positions in NVDA, XENE, MDGL, RARE, EDU, CLDX, CRNX, GERN, TNGX, STOK.
- Reduced shares in these 10 stocks: CAVA (-$385M), CYTK (-$50M), ARGX (-$44M), FOLD (-$41M), Mirati Therapeutics (-$29M), Harpoon Therapeutics (-$15M), NTRA (-$13M), RVMD (-$12M), ROIV (-$11M), SDGR (-$11M).
- Sold out of its positions in ARGX, CERE, CRIS, Cymabay Therapeutics, FUSN, Harpoon Therapeutics, IKNA, ITOS, BZ, LLY. Mirati Therapeutics, NTRA, RELY, REPL, SDGR, SNTI, ME, XLO, ROIV.
- Artal Group was a net seller of stock by $-166M.
- Artal Group has $3.9B in assets under management (AUM), dropping by 30.30%.
- Central Index Key (CIK): 0001053906
Tip: Access up to 7 years of quarterly data
Positions held by Artal Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Artal Group
Artal Group holds 107 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Cava Group Ord (CAVA) | 47.4 | $1.9B | -17% | 27M | 70.05 |
|
| Lexicon Pharmaceuticals Com New (LXRX) | 7.2 | $282M | 118M | 2.40 |
|
|
| Scholar Rock Hldg Corp (SRRK) | 5.1 | $200M | 11M | 17.76 |
|
|
| Kymera Therapeutics (KYMR) | 3.1 | $122M | +19% | 3.0M | 40.20 |
|
| Arrowhead Pharmaceuticals Call Option (ARWR) | 2.7 | $104M | +196% | 3.6M | 28.60 |
|
| Morphic Hldg (MORF) | 2.0 | $78M | +3% | 2.2M | 35.20 |
|
| Apellis Pharmaceuticals (APLS) | 2.0 | $77M | -7% | 1.3M | 58.78 |
|
| Springworks Therapeutics (SWTX) | 1.8 | $70M | -12% | 1.4M | 49.22 |
|
| Crinetics Pharmaceuticals In (CRNX) | 1.7 | $65M | NEW | 1.4M | 46.81 |
|
| Beigene Sponsored Adr (BGNE) | 1.6 | $63M | 405k | 156.39 |
|
|
| Silence Therapeutics Ads (SLN) | 1.5 | $60M | -7% | 2.8M | 21.60 |
|
| Dyne Therapeutics (DYN) | 1.1 | $43M | +24% | 1.5M | 28.39 |
|
| Revolution Medicines (RVMD) | 1.1 | $43M | -22% | 1.3M | 32.23 |
|
| Kura Oncology (KURA) | 1.0 | $41M | +8% | 1.9M | 21.33 |
|
| Neumora Therapeutics (NMRA) | 1.0 | $40M | +14% | 2.9M | 13.75 |
|
| Korro Bio (KRRO) | 1.0 | $38M | 419k | 90.00 |
|
|
| Cytokinetics Com New (CYTK) | 0.9 | $36M | -58% | 507k | 70.11 |
|
| Solid Biosciences Com New (SLDB) | 0.8 | $33M | +174% | 2.5M | 13.32 |
|
| Igm Biosciences (IGMS) | 0.8 | $30M | 3.1M | 9.65 |
|
|
| Madrigal Pharmaceuticals (MDGL) | 0.8 | $30M | NEW | 111k | 267.04 |
|
| Glycomimetics (GLYC) | 0.7 | $26M | 8.6M | 3.00 |
|
|
| WAVE Life Sciences SHS (WVE) | 0.6 | $25M | +34% | 4.1M | 6.17 |
|
| Prothena Corp SHS (PRTA) | 0.6 | $25M | +99% | 1.0M | 24.77 |
|
| Spdr Ser Tr S&p Biotech Call Option (XBI) | 0.6 | $24M | NEW | 250k | 94.89 |
|
| Vera Therapeutics Cl A (VERA) | 0.6 | $22M | NEW | 506k | 43.12 |
|
| Viking Therapeutics (VKTX) | 0.5 | $21M | NEW | 254k | 82.00 |
|
| Merus N V (MRUS) | 0.5 | $21M | NEW | 455k | 45.03 |
|
| NewAmsterdam Pharma Company Ordinary Shares (NAMS) | 0.5 | $19M | NEW | 800k | 23.65 |
|
| Tango Therapeutics (TNGX) | 0.4 | $17M | NEW | 2.2M | 7.94 |
|
| Acelyrin (SLRN) | 0.4 | $16M | -20% | 2.4M | 6.75 |
|
| Alpine Immune Sciences (ALPN) | 0.4 | $16M | +699% | 406k | 39.64 |
|
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.4 | $16M | +39% | 1.4M | 11.30 |
|
| Gossamer Bio Call Option (GOSS) | 0.4 | $16M | +10% | 14M | 1.18 |
|
| Edgewise Therapeutics (EWTX) | 0.4 | $15M | NEW | 812k | 18.24 |
|
| Syros Pharmaceuticals Com New (SYRS) | 0.3 | $13M | 2.5M | 5.35 |
|
|
| Sea Sponsored Ads (SE) | 0.3 | $13M | -36% | 238k | 53.71 |
|
| Lexeo Therapeutics (LXEO) | 0.3 | $13M | +32% | 802k | 15.68 |
|
| Astria Therapeutics (ATXS) | 0.3 | $12M | NEW | 884k | 14.07 |
|
| Amicus Therapeutics (FOLD) | 0.3 | $12M | -77% | 1.0M | 11.78 |
|
| Generation Bio (GBIO) | 0.3 | $12M | 2.8M | 4.07 |
|
|
| Xenon Pharmaceuticals (XENE) | 0.3 | $11M | NEW | 253k | 43.05 |
|
| Celldex Therapeutics Com New (CLDX) | 0.3 | $11M | NEW | 253k | 41.97 |
|
| Taysha Gene Therapies Com Shs (TSHA) | 0.3 | $11M | 3.7M | 2.87 |
|
|
| Denali Therapeutics (DNLI) | 0.3 | $10M | -37% | 503k | 20.52 |
|
| Apogee Therapeutics (APGE) | 0.3 | $10M | NEW | 153k | 66.45 |
|
| Erasca (ERAS) | 0.2 | $9.7M | 4.7M | 2.06 |
|
|
| Agenus Com New (AGEN) | 0.2 | $9.1M | 16M | 0.58 |
|
|
| Seer Com Cl A (SEER) | 0.2 | $9.0M | 4.8M | 1.90 |
|
|
| Ultragenyx Pharmaceutical (RARE) | 0.2 | $8.3M | NEW | 178k | 46.69 |
|
| Elevation Oncology (ELEV) | 0.2 | $7.8M | NEW | 1.5M | 5.13 |
|
| Ovid Therapeutics (OVID) | 0.2 | $7.6M | 2.5M | 3.05 |
|
|
| Tourmaline Bio (TRML) | 0.2 | $7.2M | +243% | 315k | 22.90 |
|
| Applied Therapeutics (APLT) | 0.2 | $6.9M | NEW | 1.0M | 6.80 |
|
| PDD Holdings Sponsored Ads (PDD) | 0.2 | $6.6M | +73% | 57k | 116.25 |
|
| Structure Therapeutics Sponsored Ads (GPCR) | 0.2 | $6.5M | +75% | 152k | 42.86 |
|
| Vigil Neuroscience (VIGL) | 0.2 | $6.2M | 1.8M | 3.41 |
|
|
| Axsome Therapeutics (AXSM) | 0.2 | $6.1M | NEW | 77k | 79.80 |
|
| Selecta Biosciences (RNAC) | 0.2 | $5.9M | 9.1M | 0.65 |
|
|
| Black Diamond Therapeutics (BDTX) | 0.1 | $5.3M | -48% | 1.0M | 5.07 |
|
| Regenxbio Inc equity us cm (RGNX) | 0.1 | $5.3M | NEW | 250k | 21.07 |
|
| Allovir (ALVR) | 0.1 | $5.0M | 6.6M | 0.75 |
|
|
| Kyverna Therapeutics | 0.1 | $5.0M | NEW | 200k | 24.84 |
|
| Foghorn Therapeutics (FHTX) | 0.1 | $4.8M | 721k | 6.71 |
|
|
| Omega Therapeutics (OMGA) | 0.1 | $4.8M | 1.3M | 3.65 |
|
|
| Paypal Holdings Call Option (PYPL) | 0.1 | $4.6M | +7% | 68k | 66.99 |
|
| Taiwan Semiconductor Mfg Sponsored Ads (TSM) | 0.1 | $4.4M | -52% | 32k | 136.05 |
|
| Geron Corporation (GERN) | 0.1 | $4.2M | NEW | 1.3M | 3.30 |
|
| Stoke Therapeutics (STOK) | 0.1 | $4.1M | NEW | 300k | 13.50 |
|
| Hookipa Pharma Inc equity (HOOK) | 0.1 | $4.0M | 5.7M | 0.71 |
|
|
| Sagimet Biosciences Com Ser A (SGMT) | 0.1 | $3.9M | -21% | 725k | 5.42 |
|
| Ke Holdings Sponsored Ads (BEKE) | 0.1 | $3.8M | +10% | 275k | 13.73 |
|
| Repare Therapeutics Ord (RPTX) | 0.1 | $3.3M | 700k | 4.71 |
|
|
| Metagenomi | 0.1 | $3.2M | NEW | 300k | 10.55 |
|
| Pepgen (PEPG) | 0.1 | $2.9M | NEW | 200k | 14.70 |
|
| Adagene Ads (ADAG) | 0.1 | $2.9M | +2% | 1.0M | 2.80 |
|
| Gritstone Oncology Ord (GRTS) | 0.1 | $2.6M | NEW | 1.0M | 2.57 |
|
| Fate Therapeutics (FATE) | 0.1 | $2.6M | NEW | 360k | 7.34 |
|
| Vor Biopharma (VOR) | 0.1 | $2.4M | -57% | 1.0M | 2.37 |
|
| Amazon (AMZN) | 0.1 | $2.2M | 12k | 180.38 |
|
|
| Janux Therapeutics (JANX) | 0.0 | $1.9M | NEW | 50k | 37.65 |
|
| NVIDIA Corporation (NVDA) | 0.0 | $1.7M | NEW | 1.9k | 903.56 |
|
| Apple (AAPL) | 0.0 | $1.7M | NEW | 10k | 171.48 |
|
| Dynatrace Com New (DT) | 0.0 | $1.7M | NEW | 36k | 46.44 |
|
| Adobe Systems Incorporated (ADBE) | 0.0 | $1.6M | NEW | 3.1k | 504.60 |
|
| New Oriental Ed & Technology Sponsored Adr (EDU) | 0.0 | $1.3M | NEW | 15k | 86.82 |
|
| Datadog Cl A Com (DDOG) | 0.0 | $1.2M | +28% | 9.6k | 123.60 |
|
| Kronos Bio (KRON) | 0.0 | $1.1M | 843k | 1.30 |
|
|
| Alphabet Cap Stk Cl A (GOOGL) | 0.0 | $1.1M | -10% | 7.0k | 150.93 |
|
| Microsoft Corporation (MSFT) | 0.0 | $1.1M | 2.5k | 420.72 |
|
|
| Snowflake Cl A (SNOW) | 0.0 | $1.1M | NEW | 6.5k | 161.60 |
|
| Intapp (INTA) | 0.0 | $1.0M | +68% | 30k | 34.30 |
|
| Ironwood Pharmaceuticals Com Cl A (IRWD) | 0.0 | $963k | 111k | 8.71 |
|
|
| Achilles Therapeutics Sponsored Ads (ACHL) | 0.0 | $944k | -66% | 755k | 1.25 |
|
| Palo Alto Networks (PANW) | 0.0 | $852k | NEW | 3.0k | 284.13 |
|
| Advanced Micro Devices (AMD) | 0.0 | $812k | +80% | 4.5k | 180.49 |
|
| Procore Technologies (PCOR) | 0.0 | $781k | 9.5k | 82.17 |
|
|
| Pegasystems (PEGA) | 0.0 | $743k | 12k | 64.64 |
|
|
| MongoDB Cl A (MDB) | 0.0 | $717k | +100% | 2.0k | 358.64 |
|
| Visa Com Cl A (V) | 0.0 | $698k | 2.5k | 279.08 |
|
|
| Confluent Class A Com (CFLT) | 0.0 | $580k | 19k | 30.52 |
|
|
| Caribou Biosciences (CRBU) | 0.0 | $542k | 105k | 5.14 |
|
|
| Cyclerion Therapeutics (CYCN) | 0.0 | $445k | 139k | 3.20 |
|
|
| Clearwater Analytics Hldgs I Cl A (CWAN) | 0.0 | $442k | +25% | 25k | 17.69 |
|
| Dlocal Class A Com (DLO) | 0.0 | $441k | +50% | 30k | 14.70 |
|
| Hippo Hldgs Com New (HIPO) | 0.0 | $439k | 24k | 18.27 |
|
|
| Tesla Motors (TSLA) | 0.0 | $352k | NEW | 2.0k | 175.79 |
|
| Mink Therapeutics (INKT) | 0.0 | $1.7k | 1.9k | 0.91 |
|
Past Filings by Artal Group
SEC 13F filings are viewable for Artal Group going back to 2012
- Artal Group 2024 Q1 filed May 13, 2024
- Artal Group 2023 Q4 filed Feb. 9, 2024
- Artal Group 2023 Q3 filed Nov. 13, 2023
- Artal Group 2023 Q2 filed Aug. 11, 2023
- Artal Group 2023 Q1 filed May 12, 2023
- Artal Group 2022 Q4 filed Feb. 13, 2023
- Artal Group 2022 Q3 filed Nov. 14, 2022
- Artal Group 2022 Q2 filed Aug. 11, 2022
- Artal Group 2022 Q1 filed May 12, 2022
- Artal Group 2021 Q4 filed Feb. 11, 2022
- Artal Group 2021 Q3 filed Nov. 12, 2021
- Artal Group 2021 Q2 filed Aug. 13, 2021
- Artal Group 2021 Q1 filed May 14, 2021
- Artal Group 2020 Q4 filed Feb. 11, 2021
- Artal Group 2020 Q3 filed Nov. 13, 2020
- Artal Group 2020 Q2 filed Aug. 14, 2020